Solara Active Pharma Sciences Limited has informed the Exchange regarding Board Meeting held on December 17, 2025 interalia to consider appointment of Mr. Mohanraj (DIN:08420411) as Additional Executive Director and Whole Time Director
SOLARA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Solara Active Pharma Sciences informed the exchange that its Board of Directors met on December 17, 2025 to consider, among other items, the appointment of Mr. Mohanraj (DIN: 08420411) as Additional Executive Director and Whole Time Director. The appointment is subject to board approval and applicable regulatory requirements. No details on tenure, remuneration, or whether the appointee is internal or external were disclosed in this filing. Further updates are likely once the board formally approves the appointment.
Adding a Whole Time Director strengthens the executive leadership bench and signals active board-level succession planning, which is generally viewed positively by shareholders, though the market impact is usually neutral until the appointee's track record becomes known.